Related Experiment Video
Updated: Sep 21, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients]
1Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Insights
High lipoprotein (a) (Lp(a)) levels are a cardiovascular risk in continuous ambulatory peritoneal dialysis (CAPD) patients. This study found Lp(a) initially decreased then increased significantly over six months, linked to peritoneal excretion and liver production.
Area of Science:
- Nephrology
- Cardiovascular Science
- Clinical Chemistry
Context:
- Elevated plasma lipids, lipoproteins, and apolipoproteins are atherosclerosis risk factors in dialysis patients.
- High serum lipoprotein (a) (Lp(a)) is an independent cardiovascular disease risk factor, particularly in continuous ambulatory peritoneal dialysis (CAPD) patients.
Purpose:
- To investigate changes in serum Lp(a) levels in CAPD patients before and at 1, 3, and 6 months after initiating CAPD.
Summary:
- Serum Lp(a) and LDL levels decreased one month post-CAPD initiation.
- Significant increases in Lp(a), LDL, and various apolipoproteins were observed at 3 and 6 months.
- Serum Lp(a) correlated with LDL, lipoprotein B, and serum albumin levels.
- Peritoneal effluents contained substantial Lp(a), suggesting excretion and potential hepatic hyperproduction as causative factors.
Impact:
- Findings highlight dynamic changes in Lp(a) during CAPD, impacting cardiovascular risk assessment.
- Identifies Lp(a) excretion into peritoneal fluid and possible hepatic overproduction as key mechanisms.
- Informs clinical management strategies for cardiovascular disease prevention in CAPD patients.
Abstract:
In hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients, an increase in plasma lipid, lipoprotein or apolipoprotein is considered to be a serious risk factor for atherosclerosis. Recently, epidemiological studies have shown that a high serum lipoprotein (a) (Lp(a)) concentration is an independent risk factor for the development of cardiovascular diseases, especially in CAPD patients. In the present study, we investigated alterations of serum Lp(a) levels, before and 1, 3 and 6 months after starting CAPD. The mean serum Lp(a) level (+/- 1SD) in 45 CAPD patients was 33.6 +/- 12.6 mg/dl. The serum Lp (a) and LDL levels were decreased one month after starting CAPD. The serum levels of Lp(a), LDL, apolipoprotein AI, AII, B, CII and E were increased significantly 3 and 6 months after starting CAPD. There was a significant correlation between the serum levels of Lp(a) and LDL (r = 0.45, p < 0.05) or lipoprotein B (r = 0.73, p < 0.001), and serum albumin (r = 0.62, p < 0.001). However, there was no significant difference in serum Lp(a) levels between cases with low and high glucose concentrations in the peritoneal effluents. The preliminary study showed that the peritoneal effluents contained a large amount of Lp(a). It appears that these changes are caused by excretion of Lp(a) into the peritoneal effluents and/or by Lp(a) hyperproduction in the liver of CAPD patients.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

